|  | Number Positive | Seroprevalence Estimates (95% CI) | ||||
---|---|---|---|---|---|---|---|
N | IgG | IgM | Ortho | IgG | IgM | Ortho | |
Overall | 1996 | 13 | 68 | 14 | 0.6 (0.3 to 1.1) | 2.7 (1.7 to 3.8) | 0.6 (0.2 to 1.1) |
Sex | |||||||
 Men | 1057 | 9 | 32 | 11 | 0.8 (0.4 to 1.6) | 2.2 (1.1 to 3.8) | 0.9 (0.3 to 1.8) |
 Women | 939 | 4 | 36 | 3 | 0.3 (0.1 to 1.1) | 3.1 (1.8 to 5.0) | 0.1 (0 to 0.9) |
Age | |||||||
 15–34 | 348 | 2 | 4 | 5 | 0.6 (0.1 to 2.1) | 0.2 (0 to 2.4) | 1.3 (0.4 to 3.4) |
 35–64 | 1181 | 5 | 45 | 6 | 0.4 (0.1 to 1.0) | 3.3 (1.9 to 4.8) | 0.4 (0 to 1.0) |
 65+ | 467 | 6 | 19 | 3 | 1.2 (0.5 to 2.8) | 3.4 (1.6 to 6.1) | 0.5 (0.1 to 1.8) |
Race/Ethnicity | |||||||
 Asian | 5 | 0 | 0 | 0 |  |  |  |
 Black/African American | 11 | 0 | 0 | 0 |  |  |  |
 Hispanic/Latino | 54 | 1 | 0 | 1 | 1.9 (0.4 to 10.2) | 0.5 (0 to 7.7) * | 1.8 (0.3 to 10.3) |
 Native American | 5 | 0 | 0 | 0 |  |  |  |
 White | 1688 | 10 | 57 | 11 | 0.5 (0.2 to 1.1) | 2.7 (1.6 to 3.9) | 0.5 (0.1 to 1.1) |
 Other / Multiple | 24 | 0 | 2 | 0 |  |  |  |
 Unknown / Declined | 209 | 2 | 8 | 2 | 0.9 (0.2 to 3.5) | 3.0 (0.9 to 7.5) | 0.8 (0.1 to 3.5) |